Induction of renal endonuclease G by cisplatin is reduced in DNase I-deficient mice

Xiaoyan Yin1, Eugene O Apostolov, Sudhir V Shah

  • 1Division of Nephrology, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA.

Insights

Cisplatin chemotherapy causes kidney damage via DNA fragmentation. This study reveals that both DNase I and endonuclease G (EndoG) contribute to this DNA damage and cell death in kidney cells.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Oncology

Background:

  • Cisplatin chemotherapy can cause significant nephrotoxicity.
  • DNA fragmentation and cell death are hallmarks of cisplatin-induced kidney injury.

Purpose of the Study:

  • To investigate the roles of specific endonucleases, DNase I and endonuclease G (EndoG), in cisplatin nephrotoxicity.
  • To determine whether EndoG contributes to DNA fragmentation observed after cisplatin treatment.

Main Methods:

  • Assessed endonuclease expression in mice after cisplatin injection.
  • Utilized immunostaining to localize endonucleases and DNA fragmentation within kidney cells.
  • Examined the effects of DNase I overexpression and EndoG gene silencing in cultured kidney cells.

Main Results:

  • Cisplatin treatment increased endonuclease G (EndoG) expression while decreasing DNase I expression.
  • Immunostaining indicated EndoG co-localization with fragmented DNA in nuclei, suggesting its role in DNA fragmentation.
  • Overexpression of DNase I induced EndoG, and gene silencing of EndoG protected cells from cisplatin-induced death.

Conclusions:

  • Both DNase I and EndoG play a role in mediating cisplatin-induced injury to kidney tubular epithelial cells.
  • Endonuclease G appears to be a key mediator of DNA fragmentation and cell death following cisplatin exposure.